Bells Corners, Canada
Bells Corners, Canada

Time filter

Source Type

NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR DISSEMINATION IN THE UNITED STATES Alignvest Acquisition II Corporation ("AQY", "we", "us" or "Corporation") announces that it has filed a final prospectus with the securities regulatory authorities in all provinces and territories of Canada, except Quebec, and has obtained a receipt therefor in respect of its initial public offering (the "Offering") of $350,000,000 of Class A Restricted Voting Units. AQY has granted the underwriters of the Offering a 30-day option following closing of the Offering (the "Closing") to purchase up to an additional 5,250,000 Class A Restricted Voting Units, at a price of $10.00 each (the "Over-Allotment Option"). The proceeds from the distribution of the Class A Restricted Voting Units (along with the proceeds from any exercise of the Over-Allotment Option granted by the Corporation) will be deposited into an escrow account and will only be released upon certain prescribed conditions. AQY increased the size of its initial public offering from $250,000,000 to $350,000,000. Together with the permanent capital committed through Forward Purchase Agreements (discussed further below), AQY will have in excess of $460,000,000 to invest. "We are extremely pleased with the strong reception that our offering has received, and with the quality of our investor base, which is primarily comprised of long-term fundamental institutions," said Reza Satchu, President and Chief Executive Officer of AQY. "We believe that the strength of our investor base, together with the additional permanent capital that we have raised, provides us with a highly attractive and differentiated proposition to potential target companies." AQY is a newly organized special purpose acquisition corporation ("SPAC") incorporated under the laws of the Province of Ontario for the purpose of effecting an acquisition of one or more businesses or assets, by way of a merger, amalgamation, arrangement, share exchange, asset acquisition, share purchase, reorganization, or any other similar business combination within a specified period of time (a "qualifying acquisition"). AQY intends to identify and consummate a qualifying acquisition with a business that we believe has the potential to deliver an attractive risk-adjusted return to AQY's shareholders. We intend to focus on businesses that have the following characteristics: are led by strong, experienced, and well-aligned founders and management teams, with a proven track record of equity value creation who want to continue to build their businesses; are known to Alignvest Management Corporation ("AMC") through a proprietary (non-auctioned) relationship; operate in an industry in which we have expertise; have the potential to generate attractive risk-adjusted returns on invested capital; and/or provide the opportunity to execute synergistic follow-on acquisitions. AQY's management team, board of directors, and advisory board have extensive experience in identifying such businesses, executing on these transactions, and subsequently unlocking shareholder value. In addition, our and AMC's team have significant experience working with private companies in preparing for, and executing, an initial public offering, and serving as active owners and directors by working closely with these companies to create value in the public markets. Notably, AMC, as the sponsor of Alignvest Acquisition Corporation ("AQX"), has experience executing a SPAC transaction, having successfully completed a qualifying acquisition with Trilogy International Partners LLC ("Trilogy") in February 2017. We believe that our ability to complete a qualifying acquisition on terms that are favourable to AQY and its shareholders will be enhanced by our having entered into forward purchase agreements ("Forward Purchase Agreements") with certain institutional and accredited investors and certain directors of AQY who have agreed to purchase an aggregate of 11,300,000 Forward Purchase Common Shares, plus an aggregate of 3,766,659 Forward Purchase Warrants, for an aggregate purchase price of $113,000,000, in a private placement to occur concurrently with the closing of our qualifying acquisition. An affiliate of our Sponsor and our Founders are committing 50% of this permanent (non-redeemable) capital, which further aligns their interests with those of AQY's shareholders. This enhanced structure, whereby approximately 24% of our total capital is permanent (not subject to redemption) (or approximately 22% in the event our Underwriters exercise the Over-Allotment Option), improves upon the structure of a traditional SPAC by having certainty on a significant portion of available cash at the time of a qualifying acquisition. We believe that this structure will not only reduce the chances of not completing an acquisition, but that it will also serve to increase the calibre of potential targets given the heightened certainty of capital. AQY's management team, board of directors, and advisory board are comprised of a group of individuals that have founded businesses, have worked as senior investment professionals at leading private equity firms, lead or have led publicly-traded companies on the Toronto Stock Exchange ("TSX") or the New York Stock Exchange, and sit on the boards of directors of industry-leading companies. The individuals in this group have founded, built and/or managed businesses including ATI Technologies Inc. (sold to Advanced Micro Devices Inc. for $5.3 billion), WIND Mobile Canada (sold to Shaw Communications for $1.6 billion), Retirement Concepts Senior Services Ltd. (sold to Anbang Insurance Group for over $1.0 billion), SupplierMarket.com, Inc. (sold to Ariba Inc. for share consideration valued at US$924 million), VoiceStream Wireless Inc. and Western Wireless Corporation. Individuals in this group hold or have held the positions of Chief Executive Officer or Chairman of prominent publicly-traded companies including Rogers Communications Inc., Telus Communications Inc., Magna International Inc. and Trilogy International Partners Inc. Additionally, individuals in this group are board members of industry-leading companies including TD Financial Group, Celestica Inc., Trilogy International Partners Inc., Magna International Inc., Microsoft Corporation, Costco Wholesale Corporation, The Public Sector Pension Investments Board, MEG Energy Corp. and Swarovski International Holdings. AQY's Board of Directors is comprised of: AQY's sponsor is Alignvest II LP (the "Sponsor"), a limited partnership of which Alignvest II Corporation is the general partner, and which is indirectly controlled by AMC, a leading alternative investment management firm that is parent to three investment platforms: Alignvest Private Capital, Alignvest Investment Management, and Alignvest Capital Management. AMC was the sponsor of AQX until it successfully completed its qualifying acquisition with Trilogy. Each Class A Restricted Voting Unit in the Offering consists of one Class A Restricted Voting Share and one-half of a Warrant. Each whole Warrant will entitle the holder to purchase one Class A Restricted Voting Share (and upon the closing of a qualifying acquisition, each whole Warrant would represent the entitlement to purchase one Common Share). The Class A Restricted Voting Units are intended to begin trading promptly after the Closing. The Class A Restricted Voting Shares and Warrants comprising the Class A Restricted Voting Units will initially trade as a unit but it is anticipated that the Class A Restricted Voting Shares and Warrants will begin trading separately 40 days following the Closing (or, if such date is not a TSX trading day, the next TSX trading day). However, no fractional Warrants will be issued and only whole Warrants will trade. The Class B Shares will not be listed at the Closing and it is anticipated that they will not be listed prior to the qualifying acquisition, as described in the final prospectus. The Closing is expected to occur on or about May 25, 2017. The TSX has conditionally approved the listing of the Class A Restricted Voting Units, the Class A Restricted Voting Shares and the Warrants (including the Warrants forming part of the Class A Restricted Voting Units, the Warrants that may be sold pursuant to the exercise of the Over-Allotment Option and the Founders' Warrants being sold pursuant to the Offering, and the Forward Purchase Warrants) under the symbols "AQY.UN", "AQY.A" and "AQY.WT", respectively, with the Class A Restricted Voting Units separating into Class A Restricted Voting Shares and Warrants 40 days following the Closing (or, if such date is not a TSX trading day, the next TSX trading day), subject to the Corporation fulfilling all of the listing requirements of the TSX, including the distribution of the Class A Restricted Voting Units to a minimum number of public holders. Our Sponsor, Vince Hemmer, Azim Jamal, Anthony Lacavera, Lee Lau, Nadir Mohamed, Joe Natale, Helmut Swarovski and Donald Walker (or persons or companies controlled by them) (which we refer to collectively as our "Founders") intend to purchase an aggregate of 10,000,000 share purchase warrants (the "Founders' Warrants") at an offering price of $1.00 per Founders' Warrant (for an aggregate purchase price of $10,000,000) that will occur simultaneously with the closing of the Offering. Our Founders intend to purchase in aggregate up to an additional 1,050,000 Founders' Warrants in the event the Underwriters exercise the Over-Allotment Option. Each whole Warrant is exercisable to purchase one Class A Restricted Voting Share (which, following the closing of the qualifying acquisition, will become one Common Share) at a price of $11.50 per share. Warrants may be exercised only for a whole number of shares. If, upon exercise of the Warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon exercise, round down to the nearest whole number of shares to be issued to the Warrant holder. The Class A Restricted Voting Units are proposed to be distributed by a syndicate of underwriters being led by Scotia Capital Inc. and Citigroup Global Markets Canada Inc., and includes BMO Nesbitt Burns Inc. TD Securities Inc., and UBS Securities Canada Inc. Stikeman Elliott LLP is acting as Canadian legal counsel and Dorsey & Whitney LLP is acting as U.S. legal counsel to Alignvest Acquisition II Corporation. Osler, Hoskin & Harcourt LLP is acting as Canadian and U.S. legal counsel to the underwriters. The Offering is only being made to the public by prospectus. A prospectus containing important information relating to these securities has been filed with the securities commissions or similar authorities in each of the provinces and territories of Canada, except Quebec. Copies of the prospectus may be obtained from any of the underwriters. Investors should read the prospectus before making an investment decision. This press release is not an offer of securities for sale in the United States, and the securities may not be offered or sold in the United States absent registration or an exemption from registration. The securities have not been and will not be registered under the United States Securities Act of 1933. Copies of the final prospectus will be available on SEDAR at www.sedar.com. Completion of AQY's initial public offering is subject to the receipt of customary approvals, including regulatory approvals. Alignvest Acquisition II Corporation is a newly organized special purpose acquisition corporation incorporated under the laws of the Province of Ontario for the purpose of effecting a qualifying acquisition. Alignvest Management Corporation is a leading alternative investment management firm that seeks to deliver superior risk-adjusted returns for its clients, which include pension plans, foundations, and ultra-high net worth family offices, by identifying and exploiting market discontinuities, and by attracting the very best talent to build industry-leading investment platforms. The partners of the firm have a strong combination of investment and operational expertise, having created and managed numerous successful operating businesses, and having built and led large, highly profitable businesses within global financial and consulting firms. Alignvest Management Corporation was formed in 2011 and has raised equity and investment capital from a number of private family offices and institutions. Alignvest Management Corporation's founding partners have committed to invest over $230 million of their personal capital into funds managed by Alignvest Management Corporation, on a fully discretionary basis, with the capital subject to full recyclability. Alignvest Management Corporation believes that this long term, discretionary, and aligned pool of capital provides the firm with a strong and differentiated foundation. Alignvest Management Corporation is headquartered in Toronto, Ontario, with an additional office in London, UK. This press release may contain forward-looking information within the meaning of applicable securities legislation, which reflects Alignvest Management Corporation's, Alignvest II LP's, and Alignvest Acquisition II Corporation's current expectations regarding future events. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond Alignvest Management Corporation's, Alignvest II LP's, or Alignvest Acquisition II Corporation's control, that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include, but are not limited to, failure to complete the Offering and related transactions, and the factors discussed under "Risk Factors" in the final prospectus of Alignvest Acquisition II Corporation dated May 18, 2017. Past performance is not indicative of future performance and may not be repeated. None of Alignvest Management Corporation, Alignvest II LP, or Alignvest Acquisition II Corporation undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.


News Article | May 23, 2017
Site: www.marketwired.com

TORONTO, ON--(Marketwired - May 23, 2017) - Celestica Inc. ( : CLS) (TSX: CLS), a global leader in the delivery of end-to-end product lifecycle solutions, today announced that Darren Myers, Chief Financial Officer, has made the decision to leave Celestica effective the end of July to pursue an opportunity in another industry. Mandeep Chawla, Senior Vice President, Finance, will immediately assume the role on an interim basis. The company will conduct a search for a permanent replacement that will include both internal and external candidates. "I want to thank Darren for his significant contributions to Celestica's success over the course of his career, including the last four and a half years as our Chief Financial Officer," said Rob Mionis, President and Chief Executive Officer, Celestica. "Under Darren's leadership, Celestica has made strong progress on its transformational journey to drive sustained profitable growth. I wish him continued success." Celestica is dedicated to delivering end-to-end product lifecycle solutions to drive our customers' success. Through our simplified global operations network and information technology platform, we are solid partners who deliver informed, flexible solutions that enable our customers to succeed in the markets they serve. Committed to providing a truly differentiated customer experience, our agile and adaptive employees share a proud history of demonstrated expertise and creativity that provides our customers with the ability to overcome complex challenges. This news release contains forward-looking statements. Such forward-looking statements are predictive in nature and may be based on current expectations, forecasts or assumptions involving risks and uncertainties that could cause actual outcomes to differ materially from the forward-looking statements themselves. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the U.S. Private Securities Litigation Reform Act of 1995, and in any applicable Canadian securities laws. Forward-looking statements are not guarantees of future actions, events or outcomes. You should understand that the risks, uncertainties and factors which are identified in our various public filings at www.sedar.com and www.sec.gov could affect our future actions, events and outcomes and could cause them to differ materially from those expressed in such forward-looking statements. Forward-looking statements are provided for the purpose of providing information about management's current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes. Except as required by applicable law, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


Wiseguyreports.Com Adds “Electronics Manufacturing Services (EMS) -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022” To Its Research Database This report studies Electronics Manufacturing Services (EMS) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering Foxconn (formerly Hon Hai Precision Industries) Flex Jabil FIH Mobile Sanmina Celestica Advanced Semiconductor Engineering (Former USI) Plexus Benchmark Electronics SIIX Market Segment by Regions, this report splits Global into several key Region, with production, consumption, revenue, market share and growth rate of Electronics Manufacturing Services (EMS) in these regions, from 2011 to 2021 (forecast), like Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by application, this report focuses on consumption, market share and growth rate of Electronics Manufacturing Services (EMS) in each application, can be divided into Application 1 Application 2 Application 3 Global Electronics Manufacturing Services (EMS) Market Research Report 2021 1 Electronics Manufacturing Services (EMS) Overview 1.1 Product Overview and Scope of Electronics Manufacturing Services (EMS) 1.2 Electronics Manufacturing Services (EMS) Segment by Types 1.2.1 Global Production Market Share of Electronics Manufacturing Services (EMS) by Type in 2015 1.2.2 Type I Overview and Price 1.2.2.1 Type I Overview 1.2.2.2 Type I Price List in 2015 and 2016 1.2.3 Type II 1.2.3.1 Type I Overview 1.2.3.2 Type I Price List in 2015 and 2016 1.2.4 Type III 1.2.4.1 Type I Overview 1.2.4.2 Type I Price List in 2015 and 2016 1.3 Electronics Manufacturing Services (EMS) Segment by Application 1.3.1 Electronics Manufacturing Services (EMS) Consumption Market Share by Application in 2015 1.3.2 Application 1 and Major Clients (Buyers) List 1.3.3 Application 2 and Major Clients (Buyers) List 1.3.4 Application 3 and Major Clients (Buyers) List 1.4 Electronics Manufacturing Services (EMS) Market by Region 1.4.1 North America Status and Prospect (2011-2021) 1.4.2 China Status and Prospect (2011-2021) 1.4.3 Europe Status and Prospect (2011-2021) 1.4.4 Japan Status and Prospect (2011-2021) 1.4.5 India Status and Prospect (2011-2021) 1.4.6 Southeast Asia Status and Prospect (2011-2021) 1.5 Global Market Size (Value and Volume) of Electronics Manufacturing Services (EMS) (2011-2021) 1.5.1 Global Electronics Manufacturing Services (EMS) Production and Revenue (2011-2021) 1.5.2 Global Electronics Manufacturing Services (EMS) Production and Growth Rate (2011-2021) 1.5.3 Global Electronics Manufacturing Services (EMS) Revenue and Growth Rate (2011-2021) 6 Global Electronics Manufacturing Services (EMS) Manufacturers Analysis 6.1 Foxconn (formerly Hon Hai Precision Industries) 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Electronics Manufacturing Services (EMS) Product Type and Technology 6.1.2.1 Type I 6.1.2.2 Type II 6.1.2.3 Type III 6.1.3 Service Production, Revenue, Price of Electronics Manufacturing Services (EMS) (2015 and 2016) 6.2 Flex 6.2.1 Company Basic Information, Manufacturing Base and Competitors 6.2.2 Electronics Manufacturing Services (EMS) Product Type and Technology 6.2.2.1 Type I 6.2.2.2 Type II 6.2.2.3 Type III 6.2.3 Flex Production, Revenue, Price of Electronics Manufacturing Services (EMS) (2015 and 2016) 6.3 Jabil 6.3.1 Company Basic Information, Manufacturing Base and Competitors 6.3.2 Electronics Manufacturing Services (EMS) Product Type and Technology 6.3.2.1 Type I 6.3.2.2 Type II 6.3.2.3 Type III 6.3.3 Jabil Production, Revenue, Price of Electronics Manufacturing Services (EMS) (2015 and 2016) 6.4 FIH Mobile 6.4.1 Company Basic Information, Manufacturing Base and Competitors 6.4.2 Electronics Manufacturing Services (EMS) Product Type and Technology 6.4.2.1 Type I 6.4.2.2 Type II 6.4.3 FIH Mobile Production, Revenue, Price of Electronics Manufacturing Services (EMS) (2015 and 2016) 6.5 Sanmina 6.5.1 Company Basic Information, Manufacturing Base and Competitors 6.5.2 Electronics Manufacturing Services (EMS) Product Type and Technology 6.5.2.1 Type I 6.5.2.2 Type II 6.5.3 Sanmina Production, Revenue, Price of Electronics Manufacturing Services (EMS) (2015 and 2016) 6.6 Celestica 6.6.1 Company Basic Information, Manufacturing Base and Competitors 6.6.2 Electronics Manufacturing Services (EMS) Product Type and Technology 6.6.2.1 Type I 6.6.2.2 Type II 6.6.3 Celestica Production, Revenue, Price of Electronics Manufacturing Services (EMS) (2015 and 2016) 6.7 Advanced Semiconductor Engineering (Former USI) 6.7.1 Company Basic Information, Manufacturing Base and Competitors 6.7.2 Electronics Manufacturing Services (EMS) Product Type and Technology 6.7.2.1 Type I 6.7.2.2 Type II 6.7.3 Advanced Semiconductor Engineering (Former USI) Production, Revenue, Price of Electronics Manufacturing Services (EMS) (2015 and 2016) 6.8 Plexus 6.8.1 Company Basic Information, Manufacturing Base and Competitors 6.8.2 Electronics Manufacturing Services (EMS) Product Type and Technology 6.8.2.1 Type I 6.8.2.2 Type II 6.8.3 Plexus Production, Revenue, Price of Electronics Manufacturing Services (EMS) (2015 and 2016) 6.9 Benchmark Electronics 6.9.1 Company Basic Information, Manufacturing Base and Competitors 6.9.2 Electronics Manufacturing Services (EMS) Product Type and Technology 6.9.2.1 Type I 6.9.2.2 Type II 6.9.3 Benchmark Electronics Production, Revenue, Price of Electronics Manufacturing Services (EMS) (2015 and 2016) 6.10 SIIX 6.10.1 Company Basic Information, Manufacturing Base and Competitors 6.10.2 Electronics Manufacturing Services (EMS) Product Type and Technology 6.10.2.1 Type I 6.10.2.2 Type II 6.10.3 SIIX Production, Revenue, Price of Electronics Manufacturing Services (EMS) (2015 and 2016) For more information, please visit https://www.wiseguyreports.com/sample-request/585788-global-electronics-manufacturing-services-ems-market-research-report-2021


The global medical device outsourcing market is expected to reach USD 88.2 billion by 2025 Rising price competition and rising need for reduction of production cost are the most impact rendering driver of the medical device outsourcing market. Sharp cutbacks in the public spending in major EU regions and the U.S., is the major issue currently faced by medical devices manufacturers. Increasing profitability pressure and growing competition coupled with high degree of industry maturity is expected to impact growth. The medical device outsourcing market is dynamic and highly competitive. Over the next seven years, the industry is expected to witness significant growth owing to steep decline in duration for product commercialization by companies in order to gain the advantage of being the first mover. Product design and development services are anticipated to be one of the highly availed services by device manufacturers over the forecast period. By opting for this service, manufacturers are expected to benefit in speeding up the time to market and faster return on investment, thereby supporting growth for this segment. Further key findings from the study suggest: - Shivna Medical Instruments Co., Ltd. - Mitutoyo Corporation - Daiichi Jitsugyo Co., Ltd. - GE Healthcare - Integer Holdings Corporation - Active Implants Corporation LLC - Cirtec Medical - MDMI Technologies, Inc. - Micro Systems Engineering GmbH - Creganna-Tactx Medical - Avail Medical Products Inc. - Sterigenics International Inc. - Hamilton Medical - Inteprod LLC - Kinetics Climax Inc. - CFI Medical - Omnica Corporation - Infinity Plastics Group - Teleflex Medical OEM - ProMed Molded Products, Inc. - Accell Clinical Research LLC - Medpace Inc. - Charles River Laboratories International Inc. - Covance Inc. - PAREXEL International Corporation - WuXi AppTec - Icon Plc - CERES GmbH Evaluation and Research - Decision Driver Analytics - PRC Clinical - Chiltern International Ltd. - Precision Bioservices - RCRI - SynteractHCR - Technomics Research - Celestica HealthTech - CoorsTek Medical LLC - Memry Corporation - Plexus Corporation - Cadence Inc. - Millstone Medical Outsourcing - HCL Technologies Ltd. - Code Refinery LLC - Phase 2 Medical Device Manufacturing - Dravon Medical Inc. For more information about this report visit http://www.researchandmarkets.com/research/5n8p78/medical_device To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-medical-device-outsourcing-market-analysis-2014-2017-and-2025---research-and-markets-300446964.html


Techonomy Returns to New York for Two Days of Intense Conversation About Technology’s Impact on Business and Society Techonomy, a leading events and media company focused on helping organizations and executives prepare for the rapid pace of tech-enabled transformation, will hold two consecutive events, Techonomy Health & Techonomy NYC, in New York City on May 16th & 17th. Techonomy, a leading events and media company focused on helping organizations and executives prepare for the rapid pace of tech-enabled transformation, will hold two consecutive events, Techonomy Health & Techonomy NYC, in New York City on May 16th & 17th. “We love our home city in New York and we love helping leaders engage with ideas about tech-driven change, so we are especially proud to be doing that here for the second year in a row,” said David Kirkpatrick, CEO and Chief Techonomist and author of the bestselling book, The Facebook Effect: The Inside Story of the Company that is Connecting the World. "We're inviting techonomic thinkers to join us for either one or both of two days – Techonomy Health first, and then Techonomy NYC on May 17." Techonomy Health explores the vast potential tech holds to remake this $3 trillion U.S. industry. The program includes healthcare experts, technologists, policy makers and entrepreneurs for a high-energy discussion around topics including how AI and CRISPR will change the war on cancer, the future of consumer health information and media, the ethical and moral quandaries of enhancing the human genome, and what Trumpcare and Obamacare mean for health innovation. Speakers include Len Greer, President, Johnson & Johnson Health and Wellness; Meredith Guerriero, director for the healthcare industry at Facebook; Arianna Huffington, Founder and CEO, Thrive Global; John Mattison, Chief Medical Information Officer, Kaiser Permanente; celebrated author and holistic medicine expert Dean Ornish; Claudia González Romo, Executive Office of the Secretary General, UNICEF; Oscar CEO Mario Schlosser; Brent Shafer, CEO of Philips North America; and Steven Zatz, CEO of WebMD. (Full list below.) The following day, Techonomy NYC will be a New York-style version of Techonomy’s longstanding retreat in California, where last fall Mark Zuckerberg famously spoke about fake news. Techonomy NYC will ignite invigorating discourse around ongoing challenges relating to what a government led by Trump means for technology; the future of work in an on-demand gig economy; the digital and social fight against terrorism; and tough-to-answer questions about decision making power in an AI world, among many other topics. Speakers include Beth Comstock, Vice Chair of GE; Karin Klein, Head of Investing Activities at VC firm Bloomberg Beta; Environmental Defense Fund President Fred Krupp; Turner CEO John Martin; Miguel McKelvey, Co-founder and Chief Creative Officer of WeWork; Eli Pariser, Co-founder and Co-CEO of Upworthy; and General Assembly CEO Jake Schwartz. (Full list below.) Techonomy's partners for the conferences include Accenture, Celestica, Cognizant, Johnson & Johnson, Paypal, Philips, Pitney-Bowes, and Turner Broadcasting. Techonomy Health confirmed speakers include: Yonatan Adiri, Founder and CEO, Healthy.io and Founder, DisruptionLabs; Agnes Binagwaho Vice Chancellor, University of Global Health Equity; Jef Boeke, Director of the Institute for Systems Genetics, NYU Langone Medical Center; Walter De Brouwer, Founder and CEO, doc.ai; Brian Donley, Chief of Staff, Cleveland Clinic; David Ewing Duncan, Co-Founder, Curator and CEO, Arc Fusion; Esther Dyson, Chairman, EDventure Holdings; Katelyn Gleason, CEO & Cofounder, Eligible; Claudia González Romo, Executive Office of the Secretary General, UNICEF; Len Greer, President, Johnson & Johnson Health and Wellness Solutions; Meredith Guerriero, director for the healthcare industry at Facebook Ron Gutman, Founder and CEO, HealthTap; Jill Hagenkord, Chief Medical Officer, Color Genomics; Arianna Huffington, Founder and CEO, Thrive Global; Nancy J. Kelley, President and CEO, Nancy J. Kelley & Associates and Former Founding Executive Director, New York Genome Center; Robert Klitzman, Director, Masters of Bioethics Program, Joseph Mailman School of Public Health, Columbia University; Tom Kottler, CEO, Co-Founder, HealthPrize Technologies; Steven Krein, Co-founder and CEO, StartUp Health; Andrew Kung, Chair and Professor, Department of Pediatrics, Memorial Sloan Kettering Cancer Center; Kristin Lemkau, Chief Marketing Officer, JPMorgan Chase; Christian Madsbjerg, Senior Partner, ReD Associates; John Mattison, Chief Medical Information Officer, Kaiser Permanente; Dan Munro, Author; Alexi Nazem, Co-founder and CEO, Nomad Health; Lynn O'Connor Vos, Chief Executive Officer, Grey Healthcare Group (ghg); Dean Ornish, President and Director, Preventive Medicine Research Institute; Meredith Salisbury, Editorial Director, Bioscribe; Mario Schlosser, Co-founder and CEO, Oscar; Brent Shafer, CEO, Philips North America; Seth Sternberg, Co-founder and CEO, Honor; Andrew Thompson, Co-founder and CEO, Proteus Digital Health, Inc.; and Steven Zatz, CEO, WebMD. Current agenda and additional information can be found at www.techonomy.com/health Techonomy NYC confirmed speakers include: Daniel Buchner, Senior PM - Head of Decentralized Identity at Microsoft, Microsoft; Beth Comstock, Vice Chair, GE; Meltem Demirors, Director, Development, Digital Currency Group; Diana Farrell, President and CEO, JPMorgan Chase Institute; Max Furmanov, Managing Director & Partner, Accenture; Andrea Glorioso, Counsellor, Digital Economy / Cyber, Delegation of the European Union to the USA; COL John Graham, Associate Dean for Research and Chief Scientist, United States Military Academy; Subramaniam Hariharan, VP Global Quality, Technology Innovation & Operational Excellence, Celestica; Jessi Hempel, Head of Editorial, Backchannel; Karin Klein, Head of Investing Activities, Bloomberg Beta; Fred Krupp, President, Environmental Defense Fund; Doreen Lorenzo, Co-founder, Vidlet Inc.; Director for the Center of Integrated Design, The University of Texas; Rachel Maguire, Research Director, Health Horizons Program, Institute for the Future; Gary Marcus, Professor, NYU; Founder, Geometric Intelligence (acquired by Uber); John Martin, Chairman and Chief Executive Officer, Turner; Miguel McKelvey, Co-founder and Chief Creative Officer, WeWork; Gregory McNeal, Co-Founder, AirMap; John Melkon, Center for the Study of Civil-Military Operations, United States Military Academy; Michael Monahan, Executive Vice President and Chief Operating Officer, Pitney Bowes; Eli Pariser, Co-founder and Co-CEO, Upworthy; Bre Pettis, Founder, Bre & Co.; Ernesto Quinteros, Chief Design Officer, Johnson & Johnson; Andrew Rasiej, Founder and Publisher, Personal Democracy Forum; Founder and CEO, Civic Hall; Slava Rubin, Chief Business Officer, Indiegogo; Julie Samuels, Executive Director, Tech:NYC; Jake Schwartz, Co-founder and CEO, General Assembly; Melanie Shapiro, Founder and CEO, Case; Oz Sultan, CEO, Sultan Interactive Group; Arun Sundararajan, Professor of Business, New York University; Author, "The Sharing Economy"; David Treat, Managing Director, Accenture; Bradley Tusk, Founder and CEO, Tusk Ventures; Michael J. Wolf, Co-founder and Managing Director, Activate, Inc.; and Tracy Young, CEO and Co-founder, PlanGrid. Current agenda and additional information can be found at www.techonomy.com/nyc Contacts: Techonomy Josh Kampel 617.233.7722 josh@techonomy.com Grayling Crystal Yang 415.593.1188 techonomy@grayling.com New York, NY, April 25, 2017 --( PR.com )-- GE’s Beth Comstock, Arianna Huffington of Thrive Global, and John Martin of Turner are among 60 speakers dissecting the role of tech on social and economic progress, and especially in health.Techonomy, a leading events and media company focused on helping organizations and executives prepare for the rapid pace of tech-enabled transformation, will hold two consecutive events, Techonomy Health & Techonomy NYC, in New York City on May 16th & 17th.“We love our home city in New York and we love helping leaders engage with ideas about tech-driven change, so we are especially proud to be doing that here for the second year in a row,” said David Kirkpatrick, CEO and Chief Techonomist and author of the bestselling book, The Facebook Effect: The Inside Story of the Company that is Connecting the World. "We're inviting techonomic thinkers to join us for either one or both of two days – Techonomy Health first, and then Techonomy NYC on May 17."Techonomy Health explores the vast potential tech holds to remake this $3 trillion U.S. industry. The program includes healthcare experts, technologists, policy makers and entrepreneurs for a high-energy discussion around topics including how AI and CRISPR will change the war on cancer, the future of consumer health information and media, the ethical and moral quandaries of enhancing the human genome, and what Trumpcare and Obamacare mean for health innovation. Speakers include Len Greer, President, Johnson & Johnson Health and Wellness; Meredith Guerriero, director for the healthcare industry at Facebook; Arianna Huffington, Founder and CEO, Thrive Global; John Mattison, Chief Medical Information Officer, Kaiser Permanente; celebrated author and holistic medicine expert Dean Ornish; Claudia González Romo, Executive Office of the Secretary General, UNICEF; Oscar CEO Mario Schlosser; Brent Shafer, CEO of Philips North America; and Steven Zatz, CEO of WebMD. (Full list below.)The following day, Techonomy NYC will be a New York-style version of Techonomy’s longstanding retreat in California, where last fall Mark Zuckerberg famously spoke about fake news. Techonomy NYC will ignite invigorating discourse around ongoing challenges relating to what a government led by Trump means for technology; the future of work in an on-demand gig economy; the digital and social fight against terrorism; and tough-to-answer questions about decision making power in an AI world, among many other topics. Speakers include Beth Comstock, Vice Chair of GE; Karin Klein, Head of Investing Activities at VC firm Bloomberg Beta; Environmental Defense Fund President Fred Krupp; Turner CEO John Martin; Miguel McKelvey, Co-founder and Chief Creative Officer of WeWork; Eli Pariser, Co-founder and Co-CEO of Upworthy; and General Assembly CEO Jake Schwartz. (Full list below.)Techonomy's partners for the conferences include Accenture, Celestica, Cognizant, Johnson & Johnson, Paypal, Philips, Pitney-Bowes, and Turner Broadcasting.Techonomy Health confirmed speakers include:Yonatan Adiri, Founder and CEO, Healthy.io and Founder, DisruptionLabs; Agnes Binagwaho Vice Chancellor, University of Global Health Equity; Jef Boeke, Director of the Institute for Systems Genetics, NYU Langone Medical Center; Walter De Brouwer, Founder and CEO, doc.ai; Brian Donley, Chief of Staff, Cleveland Clinic; David Ewing Duncan, Co-Founder, Curator and CEO, Arc Fusion; Esther Dyson, Chairman, EDventure Holdings; Katelyn Gleason, CEO & Cofounder, Eligible; Claudia González Romo, Executive Office of the Secretary General, UNICEF; Len Greer, President, Johnson & Johnson Health and Wellness Solutions; Meredith Guerriero, director for the healthcare industry at Facebook Ron Gutman, Founder and CEO, HealthTap; Jill Hagenkord, Chief Medical Officer, Color Genomics; Arianna Huffington, Founder and CEO, Thrive Global; Nancy J. Kelley, President and CEO, Nancy J. Kelley & Associates and Former Founding Executive Director, New York Genome Center; Robert Klitzman, Director, Masters of Bioethics Program, Joseph Mailman School of Public Health, Columbia University; Tom Kottler, CEO, Co-Founder, HealthPrize Technologies; Steven Krein, Co-founder and CEO, StartUp Health; Andrew Kung, Chair and Professor, Department of Pediatrics, Memorial Sloan Kettering Cancer Center; Kristin Lemkau, Chief Marketing Officer, JPMorgan Chase; Christian Madsbjerg, Senior Partner, ReD Associates; John Mattison, Chief Medical Information Officer, Kaiser Permanente; Dan Munro, Author; Alexi Nazem, Co-founder and CEO, Nomad Health; Lynn O'Connor Vos, Chief Executive Officer, Grey Healthcare Group (ghg); Dean Ornish, President and Director, Preventive Medicine Research Institute; Meredith Salisbury, Editorial Director, Bioscribe; Mario Schlosser, Co-founder and CEO, Oscar; Brent Shafer, CEO, Philips North America; Seth Sternberg, Co-founder and CEO, Honor; Andrew Thompson, Co-founder and CEO, Proteus Digital Health, Inc.; and Steven Zatz, CEO, WebMD.Current agenda and additional information can be found at www.techonomy.com/healthTechonomy NYC confirmed speakers include:Daniel Buchner, Senior PM - Head of Decentralized Identity at Microsoft, Microsoft; Beth Comstock, Vice Chair, GE; Meltem Demirors, Director, Development, Digital Currency Group; Diana Farrell, President and CEO, JPMorgan Chase Institute; Max Furmanov, Managing Director & Partner, Accenture; Andrea Glorioso, Counsellor, Digital Economy / Cyber, Delegation of the European Union to the USA; COL John Graham, Associate Dean for Research and Chief Scientist, United States Military Academy; Subramaniam Hariharan, VP Global Quality, Technology Innovation & Operational Excellence, Celestica; Jessi Hempel, Head of Editorial, Backchannel; Karin Klein, Head of Investing Activities, Bloomberg Beta; Fred Krupp, President, Environmental Defense Fund; Doreen Lorenzo, Co-founder, Vidlet Inc.; Director for the Center of Integrated Design, The University of Texas; Rachel Maguire, Research Director, Health Horizons Program, Institute for the Future; Gary Marcus, Professor, NYU; Founder, Geometric Intelligence (acquired by Uber); John Martin, Chairman and Chief Executive Officer, Turner; Miguel McKelvey, Co-founder and Chief Creative Officer, WeWork; Gregory McNeal, Co-Founder, AirMap; John Melkon, Center for the Study of Civil-Military Operations, United States Military Academy; Michael Monahan, Executive Vice President and Chief Operating Officer, Pitney Bowes; Eli Pariser, Co-founder and Co-CEO, Upworthy; Bre Pettis, Founder, Bre & Co.; Ernesto Quinteros, Chief Design Officer, Johnson & Johnson; Andrew Rasiej, Founder and Publisher, Personal Democracy Forum; Founder and CEO, Civic Hall; Slava Rubin, Chief Business Officer, Indiegogo; Julie Samuels, Executive Director, Tech:NYC; Jake Schwartz, Co-founder and CEO, General Assembly; Melanie Shapiro, Founder and CEO, Case; Oz Sultan, CEO, Sultan Interactive Group; Arun Sundararajan, Professor of Business, New York University; Author, "The Sharing Economy"; David Treat, Managing Director, Accenture; Bradley Tusk, Founder and CEO, Tusk Ventures; Michael J. Wolf, Co-founder and Managing Director, Activate, Inc.; and Tracy Young, CEO and Co-founder, PlanGrid.Current agenda and additional information can be found at www.techonomy.com/nycContacts:TechonomyJosh Kampel617.233.7722josh@techonomy.comGraylingCrystal Yang415.593.1188techonomy@grayling.com

Loading Celestica Inc. collaborators
Loading Celestica Inc. collaborators